1. Home
  2. TV vs AUPH Comparison

TV vs AUPH Comparison

Compare TV & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Televisa S.A.

TV

Grupo Televisa S.A.

HOLD

Current Price

$2.91

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.00

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TV
AUPH
Founded
1969
1993
Country
Mexico
Canada
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1993
1999

Fundamental Metrics

Financial Performance
Metric
TV
AUPH
Price
$2.91
$16.00
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$4.93
$17.25
AVG Volume (30 Days)
2.0M
1.1M
Earning Date
02-20-2026
02-26-2026
Dividend Yield
2.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
$3,246,959,081.00
$265,808,000.00
Revenue This Year
N/A
$21.76
Revenue Next Year
N/A
$16.45
P/E Ratio
N/A
$28.07
Revenue Growth
N/A
20.62
52 Week Low
$1.55
$6.55
52 Week High
$3.36
$16.54

Technical Indicators

Market Signals
Indicator
TV
AUPH
Relative Strength Index (RSI) 49.16 55.74
Support Level $2.88 $14.82
Resistance Level $3.10 $15.98
Average True Range (ATR) 0.13 0.42
MACD -0.01 -0.11
Stochastic Oscillator 9.00 66.86

Price Performance

Historical Comparison
TV
AUPH

About TV Grupo Televisa S.A.

Televisa is one of the leading telecommunication firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 5 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: